faculty photo

Wendy Galpern

Adjunct Associate Professor of Neurology
Department: Neurology

Contact information
Janssen Research & Development LLC
Janssen Pharmaceutical Companies of Johnson & Johnson
1125 Trenton-Harbourton Road
Titusville, NJ 08560
Education:
BS (Biology and Psychology)
Tufts University, 1989.
MD, PhD (Neuroscience)
University of Massachusetts Medical School and Graduate School of Biomedical Sciences, 1998.
Post-Graduate Training
Research Fellow, Harvard Medical School, McLean Hospital, 1997-1998.
Clinical Fellow in Medicine, Harvard Medical School, Boston, MA, 1998-1999.
First Year Resident in Medicine, Massachusetts General Hospital, Boston, MA, 1998-1999.
Clinical Fellow in Neurology, Harvard Medical School, Boston MA, 1999-2003.
Resident in Neurology, Massachusetts General Hospital/Brigham and Women's Hospital, Boston, MA, 1999-2002.
Clinical and Research Fellow in Movement Disorders, Massachusetts General Hospital/Brigham and Women's Hospital, Boston, MA , 2002-2003.
Clinical Fellow in Movement Disorders , Toronto Western Hospital, Toronto, ON, Canada, 2003-2005.
Postgraduate Trainee, Harvard School of Public Health, Boston, MA, 2003-2003.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Jinnah HA, Teller JK, Galpern WR: Recent developments in dystonia. Curr Opin Neurol 2016 Notes: In Press.

Comella CL, Fox SH, Bhatia KP, Perlmutter JS, Jinnah HA, Zurowski M, McDonald WM, Marsh L, Rosen AR, Waliczek T, Wright LJ, Galpern WR, Stebbins GT: Development of the comprehensive cervical dystonia rating scale: Methodology Mov Disord Clin Pract 2016 Notes: In Press.

Galpern, WR : Clinical trials for multiple system atrophy. Lancet Neurol 14(2): 126-27, 2015.

Comella CL, Perlmutter JS, Jinnah HA, Factor S, Waliczek TA, Rosen AR, Galpern WR, Goetz CG, Jankovic J, Fox SH, Reich SG, Rodriguez RL, Severt WL, Barbano RL, Adler CH, Stover N, Stebbins G: Reliability of the severity subscale of the revised Toronto Spasmodic Torticollis Rating Scale (TWSTRS-2) 67th Annual Meeting of the American Academy of Neurology 2015.

Samuel M, Rodriguez-Oroz M, Antonini A, Brotchie JM, Chaudhuri KR, Brown RG, Galpern WR, Nirenberg MJ, Okun MS, Lang AE: Management of impulse control disorders in Parkinson’s disease: Controversies and future approaches Mov Disord 30(2): 150-59, 2015.

Cedarbaum JM, Stephenson D, Rudick R, Carrillo M, Stebbins G, Kerr D, Heemskerk J, Galpern WR, Kaufmann P, Cella D, Elliott R, Isaac M, Walton M: Commonalities in the development of clinical trial measures in neurology Neurotherapeutics 12(1): 151-69, 2015.

Yan L, Hicks M, Winslow K, Comella C, Ludlow C, Jinnah HA, Rosen AR, Wright L, Galpern WR, Perlmutter JS: Secured web-based video repository for multicenter studies Parkinsonism Relat Disord 21(4): 366-71, 2015.

Neville J, Kopko S, Odenkirchen J, Galpern W, Marek K, Burn D, Ben Shlomo Y, Grosset DG, Farrer M, Romero K, Aviles E, Dubman S, Gordon M, Roach A, Stephenson D: Impact of therapeutic area specific data standards for Parkinson’s disease. 19th International Congress of Parkinson’s Disease and Movement Disorders 2015.

Galpern WR, Coffey CS, Albanese A, Cheung K, Comella CL, Ecklund DJ, Fahn S, Jankovic J, Kieburtz K, Lang AE, McDermott MP, Shefner JM, Teller JK, Thompson JLP, Yeatts SD, Jinnah HA: Designing clinical trials for dystonia. Neurotherapeutics 11(1): 117-27, 2014.

Sieber BA, Landis S, Koroshetz W, Bateman R, Siderowf A, Galpern WR, Dunlop J, Finkbeiner S, Sutherland M, Wang H, Lee VM, Orr HT, Gwinn K, Ludwig K, Taylor A, Torborg C, Montine TJ: Prioritized research recommendations from the National Institute of Neurological Disorders and Stroke Parkinson’s disease 2014 conference. Ann Neurol 76(4): 469-72, 2014 Notes: For the Parkinson's Disease 2014: Advancing Research, Improving Lives Conference Organizing Committee.

back to top
Last updated: 06/01/2016
The Trustees of the University of Pennsylvania
 

© The Trustees of the University of Pennsylvania | Site best viewed in a supported browser. | Site Design: PMACS Web Team.